1005010--2/29/2008--ARTHROCARE_CORP

related topics
{property, intellectual, protect}
{product, liability, claim}
{stock, price, operating}
{personnel, key, retain}
{operation, international, foreign}
{control, financial, internal}
{product, market, service}
{provision, law, control}
{acquisition, growth, future}
{customer, product, revenue}
We May Not Be Able to Keep Pace with Technological Change or to Successfully Develop New Products with Wide Market Acceptance, Which Could Cause Us to Lose Business to Competitors We Are Dependent Upon Our Core Coblation Technology We Face Uncertainty Over Reimbursement We Rely Exclusively on Our Costa Rica Facility to Manufacture Our High-Volume Coblation Products. If Our Costa Rica Facility is Unable to Produce Our Coblation Products in Sufficient Quantities or With Adequate Quality, or if Our Operations at Our Costa Rican Facility are Disrupted, We Will Be Forced to Find Alternative Manufacturing Options, Which Could Cause Sales to be Delayed or Increase Our Manufacturing Costs, Which Could Harm Our Reputation and Profitability We Are Dependent on Key Suppliers Circumstances Associated with Our Acquisition Strategy and Internal Growth May Adversely Affect Our Operating Results Our Business May Become Increasingly Susceptible to Risks Associated with International Operations We May Be Unable to Effectively Protect Our Intellectual Property We May Become Subject to Patent Litigation We Must Obtain Governmental Clearances or Approvals Before We Can Sell Our Products; We Must Continue to Comply with Applicable Laws and Regulations Product Liability Claims Could Adversely Impact our Financial Condition and Impair our Reputation We are Dependent Upon a Number of Key Management and Technical Personnel Our Operating Results May Fluctuate The Market Price of Our Stock May Be Highly Volatile Delaware Law and Provisions in Our Charter Could Make the Acquisition of Our Company by Another Company More Difficult

Full 10-K form ▸

related documents
739944--3/11/2008--MEDTOX_SCIENTIFIC_INC
1005010--3/24/2006--ARTHROCARE_CORP
739944--3/17/2006--MEDTOX_SCIENTIFIC_INC
739944--3/15/2007--MEDTOX_SCIENTIFIC_INC
739944--3/10/2009--MEDTOX_SCIENTIFIC_INC
882873--9/21/2009--UROLOGIX_INC
109831--3/22/2006--INAMED_CORP
880432--9/28/2009--MISONIX_INC
771252--3/8/2007--DIGITAL_ANGEL_CORP
1025573--4/2/2007--NATROL_INC
862668--9/29/2008--ESCALON_MEDICAL_CORP
827156--10/15/2007--ZILA_INC
810084--4/2/2007--BIOJECT_MEDICAL_TECHNOLOGIES_INC
862668--10/12/2010--ESCALON_MEDICAL_CORP
880432--9/26/2008--MISONIX_INC
862668--10/13/2009--ESCALON_MEDICAL_CORP
768408--6/24/2010--CYANOTECH_CORP
1013606--2/29/2008--ENDOLOGIX_INC_/DE/
827156--10/6/2008--ZILA_INC
929987--2/22/2006--GUIDANT_CORP
882873--9/29/2008--UROLOGIX_INC
1011582--9/12/2006--DIGENE_CORP
912093--8/31/2010--JDS_UNIPHASE_CORP_/CA/
893160--2/16/2007--VENTANA_MEDICAL_SYSTEMS_INC
64892--5/30/2007--MENTOR_CORP_/MN/
874710--9/28/2007--ALLIED_HEALTHCARE_PRODUCTS_INC
874710--9/26/2008--ALLIED_HEALTHCARE_PRODUCTS_INC
1042173--3/5/2009--SCIENTIFIC_LEARNING_CORP
10456--2/26/2008--BAXTER_INTERNATIONAL_INC
751978--3/19/2008--VICOR_CORP